Reducing the cost of HIV antibody testing

Area of Science:

• Public Health
• Virology
• Health Economics

Background:

• Available human immunodeficiency virus (HIV) antibody tests vary in application and cost.
• Injudicious test selection and usage can strain budgets for acquired immunodeficiency syndrome (AIDS) programs, particularly in resource-limited settings.

Purpose of the Study:

• To identify and evaluate cost-saving measures for HIV antibody testing in developing countries.
• To enhance the sustainability of HIV testing programs through financial optimization.

Main Methods:

• Analysis of cost-reduction strategies for HIV antibody detection.
• Evaluation of factors including laboratory capability alignment, testing strategy efficiency, serum sample pooling, and procurement price negotiation.

Main Results:

• Several methods can significantly reduce HIV antibody testing costs.
• These cost-saving approaches can be implemented individually or in combination for greater impact.

Conclusions:

• Optimizing the selection and use of HIV antibody tests is essential for managing healthcare budgets.
• Implementing cost-effective strategies ensures the long-term viability of HIV testing initiatives, even with limited financial resources.